HDAC9 and diabetic kidney disease: Although potential favorable effects of HDAC inhibitors have been found in animal models of acute kidney injury [19], diabetic nephropathy [20] and Adriamycin nephropathy [21], the roles of HDAC inhibitors in UUO and macrophage plasticity remain incompletely understood.